Eagle Pharmaceuticals Inc (NASDAQ:EGRX) shares are on an almost 24% cave-in today after the biotech firm’s leading pipeline program, the one the Eagle …
Top analyst Irina Rivkind Koffler at Mizuho is taking a sharp left from the sidelines on Eagle Pharmaceuticals Inc (NASDAQ:EGRX) on the heels …
Analysts are out with varied research reports on three of the biotech sector’s players: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Biogen Inc (NASDAQ:BIIB), and Eagle Pharmaceuticals …
In a research report issued Monday, Mizuho analyst Irina Rivkind Koffler downgraded shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) from Buy to Neutral, while lowering the …
In a research report released Tuesday, Cantor analyst Irina Rivkind reiterated a Buy rating on Eagle Pharmaceuticals Inc (NASDAQ:EGRX) with a $37 price target, following the …
